Esser Philipp R, Martin Stefan F
Allergy Research Group, Department of Dermatology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Hauptstrasse 7, 79104, Freiburg im Breisgau, Germany.
Curr Allergy Asthma Rep. 2017 Nov 11;17(12):83. doi: 10.1007/s11882-017-0752-8.
Contact sensitization is the initial process involved in the development of an allergic reaction to xenobiotic environmental substances. Here, we briefly describe the differences between irritant and allergic contact dermatitis. Then, we highlight the essential steps involved in the development of an ACD reaction, i.e., the protein binding of haptens, genetic factors influencing the penetration of sensitizers into the skin, the different mechanisms driving the initial development of an inflammatory cytokine micromilieu enabling the full maturation of dendritic cells, the role of pre- and pro-haptens, antigen presentation and T cell activation via MHC and CD1 molecules, dendritic cell (DC) migration, and potential LC contribution as well as the different T cell subsets involved in ACD. In addition, we discuss the latest publications regarding factors that might influence the sensitizing potential such as repeated sensitizer application, penetration enhancers, humidity of the skin, microbiota, Tregs, and phthalates. Last but not least, we briefly touch upon novel targets for drug development that might serve as treatment options for ACD.
接触致敏是对外源性环境物质发生过敏反应所涉及的初始过程。在此,我们简要描述刺激性接触性皮炎和过敏性接触性皮炎之间的差异。然后,我们重点介绍过敏性接触性皮炎(ACD)反应发生过程中的关键步骤,即半抗原的蛋白质结合、影响致敏剂渗透到皮肤的遗传因素、驱动炎症细胞因子微环境初始发展从而使树突状细胞完全成熟的不同机制、前体半抗原和半抗原的作用、通过主要组织相容性复合体(MHC)和CD1分子进行的抗原呈递和T细胞活化、树突状细胞(DC)迁移以及潜在的朗格汉斯细胞(LC)作用,以及参与ACD的不同T细胞亚群。此外,我们讨论了有关可能影响致敏潜力的因素的最新出版物,如重复应用致敏剂、渗透促进剂、皮肤湿度、微生物群、调节性T细胞(Tregs)和邻苯二甲酸盐。最后但同样重要的是,我们简要提及了可能作为ACD治疗选择的药物开发新靶点。
Curr Allergy Asthma Rep. 2017-11-11
Eur J Dermatol. 2009
Eur J Dermatol. 2004
J Dtsch Dermatol Ges. 2003-8
Allergy. 2009-10-12
J Invest Dermatol. 2006-4
J Allergy Clin Immunol. 2014-4-25
Int J Mol Sci. 2023-11-6
Environ Health Perspect. 2022-10
J Mater Sci Mater Med. 2022-6-13
Eur Heart J Case Rep. 2022-5-5
Front Toxicol. 2022-2-22
Postepy Dermatol Alergol. 2021-12
Contact Dermatitis. 2017-8-9
Contact Dermatitis. 2017-8-9
JAAD Case Rep. 2017-7-19
Contact Dermatitis. 2017-7-21
Clin Exp Allergy. 2017-8-11
J Control Release. 2017-9-10
Contact Dermatitis. 2017-7-5